BAYN.DE - Bayer Aktiengesellschaft
| Previous close | 96.63 |
| Open | 97.04 |
| Bid | 0.00 x 28400 |
| Ask | 0.00 x 2100 |
| Day's range | 96.45 - 97.51 |
| 52-week range | 87.40 - 120.90 |
| Volume | 2,760,836 |
| Avg. volume | 3,160,485 |
| Market cap | 83.218B |
| Beta | 0.88 |
| PE ratio (TTM) | 11.73 |
| EPS (TTM) | 8.26 |
| Earnings date | 5 Sep 2018 |
| Forward dividend & yield | 2.76 (2.75%) |
| Ex-dividend date | 2018-05-28 |
| 1y target est | 120.99 |
- Bloomberg•yesterday
Finding Cancer Patients Is Pharma Industry's Unlikely Challenge
The world’s biggest pharmaceutical companies, looking to sell a new type of cancer drug that could transform treatment, are grappling with an unusual challenge: finding patients. The new medicines aim to shrink tumors by targeting a rare genetic anomaly -- appearing in 1,500 to 5,000 patients’ tumors in the U.S. annually -- that can spur cancer’s growth. Bayer AG is out in front with a drug that could go on sale by the end of the year.
- EQS Group•2 days ago
Bayer Aktiengesellschaft: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Bayer Aktiengesellschaft / Total Voting Rights Announcement19.06.2018 / 17:33 Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Publication of total number of voting rights1. Details of issuerBayer AktiengesellschaftKaiser-Wilhelm-Allee 151373 LeverkusenGermany2. Type of capital measure Type of capital measureDate of status / date of effect Conditional capital increase (Sec. 41 para. 2 WpHG)XOther capital measure (Sec. 41 para. 1 WpHG)19 Jun 20183. ...
- Bloomberg•2 days ago
Bayer's Bond Sale Targets Monsanto Acquisition Funds
Bayer AG launched Europe's second-largest corporate bond sale this year, putting the company on track to complete a two-day, $21 billion fundraising drive to pay for the Monsanto Co. acquisition. Bloomberg's ...
- Bloomberg•2 days ago
$21 Billion Shows Two Bond Markets Aren't Equal
Bayer AG is finding it harder to sell debt in its home country than in the U.S., a telling sign of the respective health of the euro and dollar credit markets. The German chemical giant wanted to complete the financing for its $63 billion acquisition of Monsanto Co. — but it had to pay up to do that in Europe. Once the new issue premium — the extra yield investors are offered to buy the new securities over existing ones of a comparable maturity — was reduced by the underwriters, the bonds were eventually priced close to where Bayer's existing bonds are trading.
- Bloomberg•3 days ago
Bayer’s Bond Puts the Fed in Its Place
German chemical giant Bayer AG has finally launched one of the biggest corporate bond sales of the year. This is an important test of the health of the market, given the Federal Reserve’s move last week to raise rates and stoke expectations for additional tightening.
- Bloomberg•3 days ago
Monsanto Faces Man Dying of Cancer in Roundup Trial
Lee Johnson’s doctors didn’t think he’d live long enough to testify in court that exposure to Monsanto Co.’s Roundup weed killer caused his deadly cancer. As groundskeeper for the school district in Benicia, California, about 40 miles east of San Francisco, Johnson mixed and sprayed hundreds of gallons of Roundup. Glyphosate, the main ingredient in Roundup, was first approved for use in Monsanto’s weed killer in 1974.
- Simply Wall St.•9 days ago
Should Bayer Aktiengesellschaft’s (FRA:BAYN) Recent Earnings Decline Worry You?
Examining Bayer Aktiengesellschaft’s (DB:BAYN) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations, which isRead More...
- Motley Fool•13 days ago
Warren Buffett's Cash "Problem" Just Got $2.4 Billion Worse
Thanks to a big merger that just closed, Berkshire Hathaway’s stockpile of cash is getting even bigger.
- Forbes•13 days ago
Executive Onboarding Note: Cultural Issues In Combining Monsanto And Bayer
This week marks the end of Monsanto. After 116 years of existence, two years of due diligence and clearing regulatory hurdles its brand is disappearing into the bowels of Bayer. It certainly values Monsanto's products.
- CNBC•13 days ago
Germany's Bayer closes $63 billion Monsanto takeover, plans to drop US company's name
German conglomerate Bayer on Thursday closed its $63 billion merger with St. Louis-based agribusiness giant Monsanto and plans to drop the U.S. company's name.
- Business Insider UK•14 days ago
Germany's Bayer completes purchase of Monsanto
BERLIN (AP) — German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co.
- Business Insider UK•14 days ago
Germany's Bayer completes purchase of Monsanto
BERLIN (AP) — German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co.
- Bloomberg•14 days ago
Bayer Closes Monsanto Deal to Cap $63 Billion Transformation
Bayer AG closed its $63 billion acquisition of Monsanto Co., emerging from an arduous two-year antitrust review as the biggest seed and agricultural chemicals maker in the world. Integration should begin in about two months, once the sale of some of Bayer’s agriculture assets to BASF SE is complete. The transaction, which will double the size of Bayer’s agriculture business, means “we will be even better placed to help the world’s farmers grow more healthy and affordable food in a sustainable manner,” Bayer Chairman Werner Baumann said in a statement on Thursday.
- The Guardian•17 days ago
Monsanto to ditch its infamous name after sale to Bayer
The Monsanto company name, which has become synonymous with genetically modified food and as a longstanding target of environmental activists, will disappear after the completion of its $63bn (£47bn) sale to the German company Bayer on Thursday. Bayer, a pharmaceuticals and chemicals giant, said on Monday it would immediately retire the 117-year-old Monsanto brand name.
- Bloomberg•17 days ago
Who Needs Shareholders?
Some CEOs can go a long way without having to ask for much from their shareholders. Bayer AG's $63 billion takeover of GM-crops giant Monsanto Co. went down like a lead balloon when the plan emerged in May 2016. Many investors disliked CEO Werner Baumann's decision to tilt the pharma group's strategy towards agriculture.
- Zacks•17 days ago
Why Is Regeneron Pharmaceuticals (REGN) Up 2.7% Since Its Last Earnings Report?
Regeneron Pharmaceuticals (REGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Reuters•17 days ago
With deal to close this week, Bayer to retire Monsanto name
Germany's Bayer will wrap up the $63 billion takeover of Monsanto on Thursday and also retire the U.S. seeds maker's 117 year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. "Bayer will remain the company name.
Reuters•17 days agoWith deal to close this week, Bayer to retire Monsanto name
Germany's Bayer (BAYGn.DE) will wrap up the $63 billion takeover of Monsanto (MON.N) on Thursday and also retire the U.S. seeds maker's 117 year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. "Bayer will remain the company name.
- Associated Press•17 days ago
Germany's Bayer to complete Monsanto purchase on Thursday
BERLIN (AP) — German pharmaceutical company Bayer AG said Monday that it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators.
- Business Insider UK•17 days ago
Germany's Bayer to complete Monsanto purchase on Thursday
German pharmaceutical company Bayer AG says it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on Thursday. To obtain regulatory approval, Bayer has committed to divest some businesses, agreeing among other things to the U.S. government's demand that it sell about $9 billion in agriculture activities.
- Business Insider UK•17 days ago
Germany's Bayer to complete Monsanto purchase on Thursday
German pharmaceutical company Bayer AG says it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on Thursday. To obtain regulatory approval, Bayer has committed to divest some businesses, agreeing among other things to the U.S. government's demand that it sell about $9 billion in agriculture activities.
- Business Insider UK•17 days ago
Bayer to close Monsanto takeover, to retire target's name
Thomson Reuters
- Business Insider UK•17 days ago
Bayer to close Monsanto takeover, to retire target's name
Thomson ReutersFRANKFURT (Reuters) - Germany's Bayer will wrap up the $62.5 billion takeover of Monsanto on Thursday this week and also retire the name of the U.S. seeds maker, it said on Monday.
- The Wall Street Journal•17 days ago
[$$] Bayer in €6 Billion Cash Call for Monsanto Buyout
Bayer said it will raise €6 billion in cash from a share sale to finance its $66 billion takeover of Monsanto.
- Bloomberg Video•2 days ago
Bayer's Bond Sale Targets Monsanto Acquisition Funds
Jun.19 -- Bayer AG launched Europe's second-largest corporate bond sale this year, putting the company on track to complete a two-day, $21 billion fundraising drive to pay for the Monsanto Co. acquisition. Bloomberg's Molly Smith reports on "Bloomberg Daybreak: Americas."
